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ABSTRACT 
 
Paediatric Human Immunodeficiency Virus (HIV) remains a significant challenge to 
children and caregivers in South Africa.  Although the availability of antiretroviral (ARV) 
therapy has improved, it is not yet universally accessible.  Rates of transmission from 
mother to child thus remain high and the virus widely uncontrolled. 
 
One aspect affecting children infected with HIV is that of muscle strength.  For children 
weakness has been inferred by way of developmental studies in young children infected 
with HIV.  Impaired performance in activities such as standing, walking, stair-climbing 
and jumping have been noted.  These gross motor activities require higher muscle 
outputs and strength against gravity. 
 
This study sought to ascertain the feasibility of a full study on muscle strength in 
children infected with HIV.  It analysed the effect of HIV on muscle strength, height and 
weight of those children receiving and not receiving highly active antiretroviral therapy 
(HAART).   Children were recruited from Harriet Shezi Children’s HIV Clinic at Chris 
Hani Baragwanath Hospital, Soweto, Gauteng Province, South Africa. The study 
population included a group of children receiving HAART (n=16) and a group of children 
not receiving HAART (n=16). A once off test of muscle strength was administered to 
each child using a hand-held dynamometer. A demographic questionnaire and the 
Household Economic and Social Status Index (HESSI) were administered to their 
primary caregiver.   
 
Results showed the sample population to be of low socio-economic status (average 
score=54%) and the children to be underweight and short for their age (p<0.001).  The 
CD4 count of the group on HAART was significantly higher than the group not receiving 
HAART (p<0.05). The group not receiving HAART was significantly stronger than the 
HAART group (p<0.05).  Length of time having received HAART and muscle strength 
showed no significant correlation (p=0.647).  No significant correlation was shown 
between CD4 count and muscle strength in the group receiving HAART (p>0.1).  A 
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significant negative correlation was shown between CD4 count and muscle strength in 
the group not receiving HAART (p<0.05).  As statistically significant normative muscle 
strength data for children not infected with HIV in this age group fails to exist, the study 
was unable to ascertain a quantitative measure of weakness in these children.  
Comparison of those values available, however, showed normative values to be double 
that of children who participated in the study. 
 
The implications of these findings are that as one observes this group of children’s CD4 
count drop, so too does their muscle strength.  HAART, once initiated, stems the 
decrease in muscle strength over a period of time but does not reverse it.  Furthermore, 
children and caregivers who participated in this study were faced with the adversities of 
poor socioeconomic status, limited access to medication and ARV treatment and 
inadequate nutritional intake, most of which were largely beyond their immediate 
control.  
 
This pilot study has indicated the feasibility and importance of a full study to investigate 
the muscle strength of children infected with HIV. Further research is needed to 
establish the impact of earlier administration of HAART on muscle strength.  The effect 
of exercise on the muscle strength of children who are infected with HIV has yet to be 
documented.  The implication of these factors on gross motor development in children 
infected with HIV has yet to be investigated. 
 
 
 
 
 
 
 
A PILOT STUDY TO INVESTIGATE THE MUSCLE STRENGTH OF CHILDREN INFECTED WITH HIV 
 
 
  
 
     iv 
 
 
 
 
 
 
 
 
 
“Let the little children come to me, and do not hinder them, for the kingdom of 
God belongs to such as these.” 
 
 Luke 18:16 
        Holy Bible (NIV) 
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3TC   -   lamivudine 
AIDS   -  Acquired Immune Deficiency Syndrome 
ARV   -  Antiretroviral 
CD4    -  CD4+ T-lymphocyte 
CNS   -  Central Nervous System 
d4T    -  stavudine 
ddI    -  didanosine 
DNA    -  deoxyribonucleic acid 
EFV    -  efavirenz 
Elb Ext  -  elbow extension 
Elb Flex  -  elbow flexion 
HAART  -  Highly Active Antiretroviral Therapy 
HESSI  -   Household Economic and Social Status Index 
Hip Ext  -  hip extension  
Hip Flex  -  hip flexion  
HIV   -  Human Immunodeficiency Virus 
IDV    -  indinavir 
INH   -  isoniazid 
Knee Ext  -  knee extension   
Knee Flex  -  knee flexion 
LIP   -   lymphocytic interstitial pneumonia 
NRTI    -  nucleoside reverse transcriptase inhibitor 
NNRTI   -  non-nucleoside reverse transcriptase inhibitor 
NVP    -  nevirapine 
PCP    -  Pneumocystis jiroveci pneumonia (previously   
     Pneumocystis carinii pneumonia) 
PCR    -  polymerase chain reaction 
PI    -  protease inhibitor 
PMTCT  -  Prevention of mother-to-child transmission (of HIV) 
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Shld Abd   -  shoulder abduction  
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TB   -   tuberculosis 
UNAIDS  -  Joint United Nations Programme for HIV/AIDS 
UNICEF   -  United Nations Children’s Fund 
WBC    -  white blood cell 
WHO   -  World Health Organisation 
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